PhI to Solid Tumors and PhII to Locally Advanced or mTNBC
NCT05390710
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
21
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumor
TNBC - Triple-Negative Breast Cancer
Interventions
COMBINATION_PRODUCT:
LAE005 + Afuresertib + Nab-Paclitaxel
Sponsor
Laekna Limited